Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dehydroepiandrosterone and ageing.

Wiebke Arlt1

  • 1Division of Medical Sciences, Institute of Biomedical Research, University of Birmingham, Edgbaston, Birmingham B15 2TH, UK. w.arlt@bham.ac.uk

Best Practice & Research. Clinical Endocrinology & Metabolism
|July 21, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Steroid hormone profiling reveals altered adrenal androgen production in endometriosis.

European journal of endocrinology·2026
Same author

Corrigendum to "Effects of modified release hydrocortisone on restoration of early morning cortisol, quality of life, and fatigue in adrenal insufficiency (The CHAMPAIN study): a randomised, double-blind, double-dummy, cross-over study comparing Chronocort and Plenadren"[eClinical Medicine 91(2026); 103714].

EClinicalMedicine·2026
Same author

Endocrine and metabolic determinants of cardiometabolic risk in mild autonomous cortisol secretion.

EBioMedicine·2026
Same author

Effects of modified release hydrocortisone on restoration of early morning cortisol, quality of life, and fatigue in adrenal insufficiency (The CHAMPAIN study): a randomised, double-blind, double-dummy, cross-over study comparing Chronocort and Plenadren.

EClinicalMedicine·2026
Same author

Quantification and impact of circulating cardiotonic steroids in the RATE-AF randomised trial of patients with atrial fibrillation and heart failure.

BMC medicine·2025
Same author

Glutamine antagonism suppresses tumor growth in adrenocortical carcinoma through inhibition of de novo nucleotide biosynthesis.

bioRxiv : the preprint server for biology·2025

Dehydroepiandrosterone (DHEA) levels decline with age, but evidence does not support its use as an anti-aging hormone in healthy elderly individuals. Potential adverse effects, including tumor growth, warrant caution.

Area of Science:

  • Endocrinology
  • Aging Research
  • Neurosteroids

Background:

  • Dehydroepiandrosterone (DHEA) is a key adrenal steroid whose secretion decreases with age.
  • Its role as an 'anti-aging' hormone is under investigation, but the significance of age-related decline is unclear.
  • DHEA acts via conversion to sex steroids and potentially through direct neurosteroidal mechanisms.

Purpose of the Study:

  • To evaluate the efficacy and safety of DHEA supplementation in healthy elderly subjects.
  • To assess the role of DHEA in aging and its potential as an anti-aging therapy.

Main Methods:

  • Review of randomized, controlled trials (RCTs) investigating DHEA effects in healthy elderly populations.
  • Analysis of DHEA's mechanisms of action, including conversion to sex steroids and direct cellular effects.

Related Experiment Videos

Main Results:

  • Current RCT evidence does not support significant beneficial effects of DHEA in healthy aging individuals.
  • No major improvements were observed, and potential risks, such as promoting sex steroid-dependent tumors, were noted.

Conclusions:

  • DHEA supplementation is not currently justified for healthy elderly individuals based on available evidence.
  • Further research is needed to clarify DHEA's role in adrenal insufficiency and in patients on glucocorticoid therapy.